Open an account

Modular Medical

MODD · NASDAQ

$1.95−$0.12 (−5.80%)TodayMarket closed ·
Prev close $2.07

About MODD

Modular Medical, Inc. is a development stage company, which engages in the provision of insulin pump technology. The company is headquartered in San Diego, California and currently employs 54 full-time employees. The company went IPO on 2006-01-13. The firm is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The firm's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a baseplate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.

Employees
54
Headquarters
San Diego, California
Listed
Jan 13, 2006
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
modularmedical.com

MODD key statistics

Market cap
18.52M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
144.83K
Volume
94.89K
Open price
$2.02
High today
$2.03
Low today
$1.95
52 Week high
$18.77
52 Week low
$1.72

Modular Medical (MODD) at a glance

As of Oct 20, 2026, Modular Medical (MODD) shares are priced at $1.95, giving the company a market cap of 18.52M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.95 and $2.03. The current price is 0.0% above the day's low and 3.9% below its high.

Volume so far is 94.89K shares, below the average of 144.83K shares a day.

Over the past year Modular Medical has ranged from $1.72 to $18.77, and now sits 1% of the way up that range.

Modular Medical met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q3 FY25 it reported -$3.90 per share against an estimate of -$3.67.

MODD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 25.1% on average.

  1. Q4 FY23: reported -$9.90 per share against an estimate of -$10.40
  2. Q1 FY24: reported -$6.60 per share against an estimate of -$11.93
  3. Q2 FY24: reported -$5.70 per share against an estimate of -$6.58
  4. Q3 FY24: reported -$6.90 per share against an estimate of -$5.36
  5. Q4 FY24: reported -$4.20 per share against an estimate of -$5.36
  6. Q1 FY25: reported -$3.60 per share against an estimate of -$6.12
  7. Q2 FY25: reported -$4.20 per share against an estimate of -$3.37
  8. Q3 FY25: reported -$3.90 per share against an estimate of -$3.67

MODD news

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Vandana Singh

    Modular Medical Secures National PBM Contract For Pivot Insulin Pump

  • Vandana Singh

    EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

Similar companies

Companies in the same industry as Modular Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.